Literature DB >> 9238757

Molecular analysis of porphobilinogen (PBG) deaminase gene mutations in acute intermittent porphyria: first study in patients of Slavic origin.

R Rosipal1, H Puy, J Lamoril, P Martasek, Y Nordmann, J C Deybach.   

Abstract

Acute intermittent porphyria (AIP) is an autosomally dominant inherited metabolic disorders caused by decreased activity of porphobilinogen deaminase, the third enzyme in the human heme biosynthetic pathway. We report here the first mutations in the human porphobilinogen deaminase gene in seven unrelated patients from the Czech and Slovak Republics with acute intermittent porphyria. We used denaturing gradient gel electrophoresis to screen all 15 exons and exon/intron boundaries of the porphobilinogen deaminase gene. Polymerase chain reaction products of abnormal migration patterns were subjected to direct sequencing to identify the causative mutations. Thus we revealed four novel mutations and three which have been previously described. Of the four novel mutations, two were mis-sense (G24S, V267M), one was a single base insertion (158insA) that produced a stop codon 12 codons downstream, and one was a single base substitution in intron 12 (771 + 1) resulting in a splicing defect. The three previously detected mutations were mis-sense mutations (R26C, R26H, G111R). These results suggest a high allelic heterogeneity in Czech and Slovak patients.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9238757     DOI: 10.3109/00365519709060030

Source DB:  PubMed          Journal:  Scand J Clin Lab Invest        ISSN: 0036-5513            Impact factor:   1.713


  2 in total

1.  Mutation hotspots in the human porphobilinogen deaminase gene: recurrent mutations G111R and R173Q occurring at CpG motifs.

Authors:  X Schneider-Yin; M Hergersberg; M M Schuurmans; A Gregor; E I Minder
Journal:  J Inherit Metab Dis       Date:  2004       Impact factor: 4.982

2.  Porphobilmogen deaminase gene mutations in Brazilian acute intermittent porphyria patients.

Authors:  Georgina Severo Ribeiro; Paulo Eurípedes Marchiori; Paula Marzorati Kuntz Puglia; Maria Aparecida Nagai; Mariana Lopes Dos Santos; Kimiyo Nonoyama; Mário Hiroyuki Hirata; Orlando C O Barretto
Journal:  J Clin Lab Anal       Date:  2002       Impact factor: 2.352

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.